GRAFT-VERSUS-HOST DISEASE, RELAPSE-FREE SURVIVAL (GRFS) IN OLDER PATIENTS WITH MYELOID MALIGNANCIES IS DETERMINED BY DISEASE STAGE AND DONOR AGE BUT NOT BY THE TYPE OF THE DONOR

被引：0
|
作者：
Jindra, Pavel [1 ]
Karas, Michal [2 ]
Cepek, Pavel [1 ]
Steinerova, Katerina [2 ]
Lysak, Daniel [2 ]
机构：
[1] Czech Natl Marrow Donors Registry, Plzen, Czech Republic
[2] Univ Hosp Plzen, Plzen, Czech Republic
来源：
HLA | 2019年 / 93卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P155
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [31] Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults
    Mehta, Rohtesh S.
    de Latour, Regis Peffault
    DeFor, Todd E.
    Robin, Marie
    Lazaryan, Aleksandr
    Xhaard, Alienor
    Bejanyan, Nelli
    de Fontbrune, Flore Sicre
    Arora, Mukta
    Brunstein, Claudio G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    Socie, Gerard
    Holtan, Shernan G.
    HAEMATOLOGICA, 2016, 101 (06) : 764 - 772
  • [32] Graft-versus-host Disease-free, Relapse-free Survival After HLA-identical Sibling Peripheral Blood Stem Cell Transplantation With Tacrolimus-based Graft-versus-host Disease Prophylaxis in Japanese Patients
    Shingaki, S.
    Tsukada, N.
    Ikeda, M.
    Suzuki, K.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 241 - 245
  • [33] Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm
    Muranushi, Hiroyuki
    Shindo, Takero
    Hishizawa, Masakatsu
    Tokunaga, Masahito
    Wake, Atsushi
    Nakano, Nobuaki
    Eto, Tetsuya
    Hidaka, Michihiro
    Choi, Ilseung
    Miyamoto, Toshihiro
    Uchida, Naoyuki
    Moriuchi, Yukiyoshi
    Miyazaki, Yasuhiko
    Fukuda, Takahiro
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kato, Koji
    BLOOD, 2019, 134
  • [34] Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
    Holtan, Shernan G.
    DeFor, Todd E.
    Lazaryan, Aleksandr
    Bejanyan, Nelli
    Arora, Mukta
    Brunstein, Claudio G.
    Blazer, Bruce R.
    MacMillan, Margaret L.
    Weisdorf, Daniel J.
    BLOOD, 2015, 125 (08) : 1333 - 1338
  • [35] Tolerance for graft-versus-host disease by intrathymic of recipient-type splenocytes into donor
    Vaidya, S
    Wang, CC
    Roorda, C
    Fish, JC
    HUMAN IMMUNOLOGY, 1996, 49 : 191 - 191
  • [36] Validation of the Composite End Point of Graft-Versus Host Disease-Free, Relapse-Free Survival
    Motohashi, Kenji
    Tanaka, Masatsugu
    Taguchi, Jun
    Hagihara, Maki
    Matsumoto, Kenji
    Fujimaki, Katsumichi
    Tachibana, Takayoshi
    Sakai, Rika
    Numata, Ayumi
    Fujita, Hiroyuki
    Kawasaki, Rika
    Fujii, Eriko
    Yamazaki, Etsuko
    Kanamori, Heiwa
    Yamamoto, Wataru
    Koharazawa, Hideyuki
    Nakajima, Yuki
    Yamamoto, Eri
    Takahashi, Hiroyuki
    Fujisawa, Shin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S339 - S340
  • [37] Graft-versus-host disease (GVHD) and GVHD-free/relapse-free survival (GRFS) in patients with myelodysplastic syndrome (MDS) after treosulfan- versus busulfan-based conditioning and allogeneic hematopoietic cell transplantation (alloHCT)
    Stelljes, M.
    Trenschel, R.
    Beelen, D.
    Markiewicz, M.
    Wagner-Drouet, E-M
    Bethge, W.
    Remenyi, P.
    Niederwieser, D.
    Grigoleit, G. U.
    Schaefer-Eckart, K.
    Stoelzel, F.
    Ciceri, F.
    Dreger, P.
    Junghanss, C.
    Holler, E.
    Rambaldi, A.
    Russo, D.
    Verbeek, M.
    Casper, J.
    Patriarca, F.
    Bieniaszewska, M.
    Glass, B.
    Scheid, C.
    Basara, N.
    Finke, J.
    Hilgendorf, I.
    Labussiere-Wallet, H.
    Stuhler, G.
    Schroeder, T.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 37 - 37
  • [38] Current Graft-versus-Host Disease-Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic Transplant
    Solomon, Scott R.
    Sizemore, Connie
    Zhang, Xu
    Ridgeway, Michelle
    Solh, Melhem
    Morris, Lawrence E.
    Holland, H. Kent
    Bashey, Asad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1208 - 1214
  • [39] Testicular relapse of AML during chronic graft-versus-host disease induced by donor leukocyte infusion
    Tringali, S
    Vasta, S
    Scime, R
    Catania, P
    Cavallaro, AM
    Majolino, I
    HAEMATOLOGICA, 1996, 81 (04) : 339 - 342
  • [40] Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
    Liu, Yao-Chung
    Chien, Sheng-Hsuan
    Fan, Nai-Wen
    Hu, Ming-Hung
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Chiou, Tzeon-Jye
    Tzeng, Cheng-Hwai
    Chen, Po-Min
    Liu, Jin-Hwang
    STEM CELLS INTERNATIONAL, 2016, 2016
12345